Availability of the mouse draft genome sequence will facilitate experimental manipulation of novel drug targets and accelerate drug discovery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mouse Genome Sequencing Consortium Nature 420, 520–562 (2002).
The FANTOM Consortium and the RIKEN Genome Exploration Research Group Phase I & II Team Nature 420, 563–573 (2002).
International Human Genome Sequencing Consortium. Nature 409, 860–921 (2001).
Dermitzakis, E.T. et al. Nature 420, 578–582 (2002).
Wade, C.M. et al. Nature 420, 574–578 (2002).
Reymond, A. et al. Nature 420, 582–586 (2002).
Gitton, Y. et al. Nature 420, 586–590 (2002).
Zambrowicz, B.P. & Sands, A.T. Nature Reviews Drug Discovery 2, 37–50 (2003).
Walke, D.W. et al., Curr. Opin. Biotechnol. 12, 626–631 (2001).
Zambrowicz, B.P. et al., Nature 392, 608–611 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sands, A. The master mammal. Nat Biotechnol 21, 31–32 (2003). https://doi.org/10.1038/nbt0103-31
Issue Date:
DOI: https://doi.org/10.1038/nbt0103-31